Advertisement

Aprea Therapeutics, Inc. APRE

Set alert

Price alert · APRE

All alert types
0.49 USD +0.01 +1.32%

At close · Nov 2

0.48 -0.01 -1.28%

After hours · Nov 2, 4:00 PM ET

Bid
0.48 × 2
Ask
0.50 × 2
0.488 Day range 0.5199
0.41 52-week range 1.49
YTD
-42.44%
1 year
-64.93%
Open
0.50
Prev close
0.4846
Mkt cap
6.18M
Vol
89.06K
Avg vol
310.11K
EPS
-0.95
P/E
0.00
Div yield
0.00%
More statistics
Low
0.488
High
0.5199
Forward P/E
-3.08
Beta
1.74
Short ratio
0.55
Inst. own
43.85%
Dividend
0.00
Ex-div date
Earnings
Aug 12, 2024
50-d avg
3.48
200-d avg
4.17
1y target
15.67

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for APRE has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $148.90KExpenses → Gross Loss: $1.79MExpenses → Selling, General & Admin: $1.59MExpenses → Research & Development: $1.91MOther Operating Income → Expenses: $1.91MNet Loss → Expenses: $3.24MRevenue → Cost of Revenue: $118.11KOther Income$148.90KOther Operating Income$1.91MNet Loss$3.24MCost of Revenue$1.91MExpenses$5.30MGross Loss$1.79MSelling, General & Admin$1.59MResearch & Development$1.91MRevenue$118.11K

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

APRE quarterly income statement
4.03M
2.46M
1.57M
-4.03M
-3.59M
-3.59M
-3.59M
-3.59M
-0.07
-0.07
-0.07
-3.59M
-3.59M
53.48M
53.48M

Balance sheet

APRE quarterly balance sheet
41.28M
41.28M
41.91M
64.03K
42.29M
3.09M
3.82M
-340.52M
-10.62M
38.47M
38.47M
376.81K
727.36K
935.14K

Cash flow

APRE quarterly cash flow
5.75K
-1.94M
-5.23M
-1.94M
-3.28M
-695
103.19K
Advertisement